High-speed detection of the two common paraoxonase polymorphism Leu55→Met and Gln192←Arg by real-time fluorescence PCR and melting curves

M. Harangi, Charalampos Aslanidis, G. Paragh, Gerd Schmitz

Research output: Contribution to journalArticle

Abstract

Human paraoxonase (PON1) is a calcium-dependent esterase exclusively bound to apolipoprotein A-I and clusterin, containing high-density lipoprotein (HDL) particles that hydrolyzes organophosphates and aryl esters. Several studies have indicated that PON1 can prevent low-density lipoprotein (LDL) oxidation by hydrolyzing lipid peroxides in the lipoprotein, which is the crucial first step for atherogenesis. Therefore it may protect against the development of atherosclerosis. Serum PON1 activity has been shown to be decreased in familiar hypercholesterolemia and in diseases that are associated with accelerated atherogenesis. The PON1 gene has two common coding region polymorphisms, Leu55→Met and Gln192→Arg. Both polymorphisms have been identified as independent risk factors for cardiovascular disease in diabetic and non-diabetic patients. We have established high-speed and easy-to-perform genotyping for the two most significant PON1 gene polymorphisms, employing the LightCycler technology and melting curves. This technique eliminates PCR contamination related to sample handling and does not require digestion of PCR products with restriction enzymes and/or fragment separation on gels.

Original languageEnglish
Pages (from-to)337-340
Number of pages4
JournalClinical Chemistry and Laboratory Medicine
Volume40
Issue number4
Publication statusPublished - 2002

Fingerprint

Aryldialkylphosphatase
Polymorphism
Freezing
Real-Time Polymerase Chain Reaction
Atherosclerosis
Melting
Fluorescence
Genes
Clusterin
Polymerase Chain Reaction
Organophosphates
Lipid Peroxides
Apolipoprotein A-I
Esterases
HDL Lipoproteins
Hypercholesterolemia
LDL Lipoproteins
Lipoproteins
Digestion
Esters

Keywords

  • Paraoxonase
  • Real-time fluorescence genotyping
  • Single nucleotide polymorphisms

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

@article{5aa6147ec4fb42569ca6d888f2b82e90,
title = "High-speed detection of the two common paraoxonase polymorphism Leu55→Met and Gln192←Arg by real-time fluorescence PCR and melting curves",
abstract = "Human paraoxonase (PON1) is a calcium-dependent esterase exclusively bound to apolipoprotein A-I and clusterin, containing high-density lipoprotein (HDL) particles that hydrolyzes organophosphates and aryl esters. Several studies have indicated that PON1 can prevent low-density lipoprotein (LDL) oxidation by hydrolyzing lipid peroxides in the lipoprotein, which is the crucial first step for atherogenesis. Therefore it may protect against the development of atherosclerosis. Serum PON1 activity has been shown to be decreased in familiar hypercholesterolemia and in diseases that are associated with accelerated atherogenesis. The PON1 gene has two common coding region polymorphisms, Leu55→Met and Gln192→Arg. Both polymorphisms have been identified as independent risk factors for cardiovascular disease in diabetic and non-diabetic patients. We have established high-speed and easy-to-perform genotyping for the two most significant PON1 gene polymorphisms, employing the LightCycler technology and melting curves. This technique eliminates PCR contamination related to sample handling and does not require digestion of PCR products with restriction enzymes and/or fragment separation on gels.",
keywords = "Paraoxonase, Real-time fluorescence genotyping, Single nucleotide polymorphisms",
author = "M. Harangi and Charalampos Aslanidis and G. Paragh and Gerd Schmitz",
year = "2002",
language = "English",
volume = "40",
pages = "337--340",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "4",

}

TY - JOUR

T1 - High-speed detection of the two common paraoxonase polymorphism Leu55→Met and Gln192←Arg by real-time fluorescence PCR and melting curves

AU - Harangi, M.

AU - Aslanidis, Charalampos

AU - Paragh, G.

AU - Schmitz, Gerd

PY - 2002

Y1 - 2002

N2 - Human paraoxonase (PON1) is a calcium-dependent esterase exclusively bound to apolipoprotein A-I and clusterin, containing high-density lipoprotein (HDL) particles that hydrolyzes organophosphates and aryl esters. Several studies have indicated that PON1 can prevent low-density lipoprotein (LDL) oxidation by hydrolyzing lipid peroxides in the lipoprotein, which is the crucial first step for atherogenesis. Therefore it may protect against the development of atherosclerosis. Serum PON1 activity has been shown to be decreased in familiar hypercholesterolemia and in diseases that are associated with accelerated atherogenesis. The PON1 gene has two common coding region polymorphisms, Leu55→Met and Gln192→Arg. Both polymorphisms have been identified as independent risk factors for cardiovascular disease in diabetic and non-diabetic patients. We have established high-speed and easy-to-perform genotyping for the two most significant PON1 gene polymorphisms, employing the LightCycler technology and melting curves. This technique eliminates PCR contamination related to sample handling and does not require digestion of PCR products with restriction enzymes and/or fragment separation on gels.

AB - Human paraoxonase (PON1) is a calcium-dependent esterase exclusively bound to apolipoprotein A-I and clusterin, containing high-density lipoprotein (HDL) particles that hydrolyzes organophosphates and aryl esters. Several studies have indicated that PON1 can prevent low-density lipoprotein (LDL) oxidation by hydrolyzing lipid peroxides in the lipoprotein, which is the crucial first step for atherogenesis. Therefore it may protect against the development of atherosclerosis. Serum PON1 activity has been shown to be decreased in familiar hypercholesterolemia and in diseases that are associated with accelerated atherogenesis. The PON1 gene has two common coding region polymorphisms, Leu55→Met and Gln192→Arg. Both polymorphisms have been identified as independent risk factors for cardiovascular disease in diabetic and non-diabetic patients. We have established high-speed and easy-to-perform genotyping for the two most significant PON1 gene polymorphisms, employing the LightCycler technology and melting curves. This technique eliminates PCR contamination related to sample handling and does not require digestion of PCR products with restriction enzymes and/or fragment separation on gels.

KW - Paraoxonase

KW - Real-time fluorescence genotyping

KW - Single nucleotide polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=0036000815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036000815&partnerID=8YFLogxK

M3 - Article

C2 - 12059071

AN - SCOPUS:0036000815

VL - 40

SP - 337

EP - 340

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 4

ER -